Molecular diagnostic experience of whole-exome sequencing in adult patients

Jennifer E. Posey, Jill A. Rosenfeld, Regis A. James, Matthew Bainbridge, Zhiyv Niu, Xia Wang, Shweta Dhar, Wojciech Wiszniewski, Zeynep H C Akdemir, Tomasz Gambin, Fan Xia, Richard E. Person, Magdalena Walkiewicz, Chad A. Shaw, V. Reid Sutton, Arthur L. Beaudet, Donna Muzny, Christine M. Eng, Yaping Yang, Richard A. GibbsJames R. Lupski, Eric Boerwinkle, Sharon E. Plon

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Purpose:Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or developmental disorders. We describe the diagnostic yield and characteristics of WES in adults.Methods:We performed a retrospective analysis of consecutive WES reports for adults from a diagnostic laboratory. Phenotype composition was determined using Human Phenotype Ontology terms.Results:Molecular diagnoses were reported for 17.5% (85/486) of adults, which is lower than that for a primarily pediatric population (25.2%; P = 0.0003); the diagnostic rate was higher (23.9%) for those 18-30 years of age compared to patients older than 30 years (10.4%; P = 0.0001). Dual Mendelian diagnoses contributed to 7% of diagnoses, revealing blended phenotypes. Diagnoses were more frequent among individuals with abnormalities of the nervous system, skeletal system, head/neck, and growth. Diagnostic rate was independent of family history information, and de novo mutations contributed to 61.4% of autosomal dominant diagnoses.Conclusion:Early WES experience in adults demonstrates molecular diagnoses in a substantial proportion of patients, informing clinical management, recurrence risk, and recommendations for relatives. A positive family history was not predictive, consistent with molecular diagnoses often revealed by de novo events, informing the Mendelian basis of genetic disease in adults.

Original languageEnglish (US)
Pages (from-to)678-685
Number of pages8
JournalGenetics in Medicine
Volume18
Issue number7
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Exome
Molecular Pathology
Phenotype
Dual (Psychiatry) Diagnosis
Pediatrics
Nervous System Malformations
Inborn Genetic Diseases
Risk Management
Nervous System
Neck
Head
Medicine
Recurrence
Mutation
Growth
Population

Keywords

  • adult patients
  • whole-exome sequencing

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Posey, J. E., Rosenfeld, J. A., James, R. A., Bainbridge, M., Niu, Z., Wang, X., ... Plon, S. E. (2016). Molecular diagnostic experience of whole-exome sequencing in adult patients. Genetics in Medicine, 18(7), 678-685. https://doi.org/10.1038/gim.2015.142

Molecular diagnostic experience of whole-exome sequencing in adult patients. / Posey, Jennifer E.; Rosenfeld, Jill A.; James, Regis A.; Bainbridge, Matthew; Niu, Zhiyv; Wang, Xia; Dhar, Shweta; Wiszniewski, Wojciech; Akdemir, Zeynep H C; Gambin, Tomasz; Xia, Fan; Person, Richard E.; Walkiewicz, Magdalena; Shaw, Chad A.; Sutton, V. Reid; Beaudet, Arthur L.; Muzny, Donna; Eng, Christine M.; Yang, Yaping; Gibbs, Richard A.; Lupski, James R.; Boerwinkle, Eric; Plon, Sharon E.

In: Genetics in Medicine, Vol. 18, No. 7, 01.07.2016, p. 678-685.

Research output: Contribution to journalArticle

Posey, JE, Rosenfeld, JA, James, RA, Bainbridge, M, Niu, Z, Wang, X, Dhar, S, Wiszniewski, W, Akdemir, ZHC, Gambin, T, Xia, F, Person, RE, Walkiewicz, M, Shaw, CA, Sutton, VR, Beaudet, AL, Muzny, D, Eng, CM, Yang, Y, Gibbs, RA, Lupski, JR, Boerwinkle, E & Plon, SE 2016, 'Molecular diagnostic experience of whole-exome sequencing in adult patients', Genetics in Medicine, vol. 18, no. 7, pp. 678-685. https://doi.org/10.1038/gim.2015.142
Posey JE, Rosenfeld JA, James RA, Bainbridge M, Niu Z, Wang X et al. Molecular diagnostic experience of whole-exome sequencing in adult patients. Genetics in Medicine. 2016 Jul 1;18(7):678-685. https://doi.org/10.1038/gim.2015.142
Posey, Jennifer E. ; Rosenfeld, Jill A. ; James, Regis A. ; Bainbridge, Matthew ; Niu, Zhiyv ; Wang, Xia ; Dhar, Shweta ; Wiszniewski, Wojciech ; Akdemir, Zeynep H C ; Gambin, Tomasz ; Xia, Fan ; Person, Richard E. ; Walkiewicz, Magdalena ; Shaw, Chad A. ; Sutton, V. Reid ; Beaudet, Arthur L. ; Muzny, Donna ; Eng, Christine M. ; Yang, Yaping ; Gibbs, Richard A. ; Lupski, James R. ; Boerwinkle, Eric ; Plon, Sharon E. / Molecular diagnostic experience of whole-exome sequencing in adult patients. In: Genetics in Medicine. 2016 ; Vol. 18, No. 7. pp. 678-685.
@article{c42be66bd97a4aa89e4c2d7d2effad98,
title = "Molecular diagnostic experience of whole-exome sequencing in adult patients",
abstract = "Purpose:Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or developmental disorders. We describe the diagnostic yield and characteristics of WES in adults.Methods:We performed a retrospective analysis of consecutive WES reports for adults from a diagnostic laboratory. Phenotype composition was determined using Human Phenotype Ontology terms.Results:Molecular diagnoses were reported for 17.5{\%} (85/486) of adults, which is lower than that for a primarily pediatric population (25.2{\%}; P = 0.0003); the diagnostic rate was higher (23.9{\%}) for those 18-30 years of age compared to patients older than 30 years (10.4{\%}; P = 0.0001). Dual Mendelian diagnoses contributed to 7{\%} of diagnoses, revealing blended phenotypes. Diagnoses were more frequent among individuals with abnormalities of the nervous system, skeletal system, head/neck, and growth. Diagnostic rate was independent of family history information, and de novo mutations contributed to 61.4{\%} of autosomal dominant diagnoses.Conclusion:Early WES experience in adults demonstrates molecular diagnoses in a substantial proportion of patients, informing clinical management, recurrence risk, and recommendations for relatives. A positive family history was not predictive, consistent with molecular diagnoses often revealed by de novo events, informing the Mendelian basis of genetic disease in adults.",
keywords = "adult patients, whole-exome sequencing",
author = "Posey, {Jennifer E.} and Rosenfeld, {Jill A.} and James, {Regis A.} and Matthew Bainbridge and Zhiyv Niu and Xia Wang and Shweta Dhar and Wojciech Wiszniewski and Akdemir, {Zeynep H C} and Tomasz Gambin and Fan Xia and Person, {Richard E.} and Magdalena Walkiewicz and Shaw, {Chad A.} and Sutton, {V. Reid} and Beaudet, {Arthur L.} and Donna Muzny and Eng, {Christine M.} and Yaping Yang and Gibbs, {Richard A.} and Lupski, {James R.} and Eric Boerwinkle and Plon, {Sharon E.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1038/gim.2015.142",
language = "English (US)",
volume = "18",
pages = "678--685",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Molecular diagnostic experience of whole-exome sequencing in adult patients

AU - Posey, Jennifer E.

AU - Rosenfeld, Jill A.

AU - James, Regis A.

AU - Bainbridge, Matthew

AU - Niu, Zhiyv

AU - Wang, Xia

AU - Dhar, Shweta

AU - Wiszniewski, Wojciech

AU - Akdemir, Zeynep H C

AU - Gambin, Tomasz

AU - Xia, Fan

AU - Person, Richard E.

AU - Walkiewicz, Magdalena

AU - Shaw, Chad A.

AU - Sutton, V. Reid

AU - Beaudet, Arthur L.

AU - Muzny, Donna

AU - Eng, Christine M.

AU - Yang, Yaping

AU - Gibbs, Richard A.

AU - Lupski, James R.

AU - Boerwinkle, Eric

AU - Plon, Sharon E.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Purpose:Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or developmental disorders. We describe the diagnostic yield and characteristics of WES in adults.Methods:We performed a retrospective analysis of consecutive WES reports for adults from a diagnostic laboratory. Phenotype composition was determined using Human Phenotype Ontology terms.Results:Molecular diagnoses were reported for 17.5% (85/486) of adults, which is lower than that for a primarily pediatric population (25.2%; P = 0.0003); the diagnostic rate was higher (23.9%) for those 18-30 years of age compared to patients older than 30 years (10.4%; P = 0.0001). Dual Mendelian diagnoses contributed to 7% of diagnoses, revealing blended phenotypes. Diagnoses were more frequent among individuals with abnormalities of the nervous system, skeletal system, head/neck, and growth. Diagnostic rate was independent of family history information, and de novo mutations contributed to 61.4% of autosomal dominant diagnoses.Conclusion:Early WES experience in adults demonstrates molecular diagnoses in a substantial proportion of patients, informing clinical management, recurrence risk, and recommendations for relatives. A positive family history was not predictive, consistent with molecular diagnoses often revealed by de novo events, informing the Mendelian basis of genetic disease in adults.

AB - Purpose:Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or developmental disorders. We describe the diagnostic yield and characteristics of WES in adults.Methods:We performed a retrospective analysis of consecutive WES reports for adults from a diagnostic laboratory. Phenotype composition was determined using Human Phenotype Ontology terms.Results:Molecular diagnoses were reported for 17.5% (85/486) of adults, which is lower than that for a primarily pediatric population (25.2%; P = 0.0003); the diagnostic rate was higher (23.9%) for those 18-30 years of age compared to patients older than 30 years (10.4%; P = 0.0001). Dual Mendelian diagnoses contributed to 7% of diagnoses, revealing blended phenotypes. Diagnoses were more frequent among individuals with abnormalities of the nervous system, skeletal system, head/neck, and growth. Diagnostic rate was independent of family history information, and de novo mutations contributed to 61.4% of autosomal dominant diagnoses.Conclusion:Early WES experience in adults demonstrates molecular diagnoses in a substantial proportion of patients, informing clinical management, recurrence risk, and recommendations for relatives. A positive family history was not predictive, consistent with molecular diagnoses often revealed by de novo events, informing the Mendelian basis of genetic disease in adults.

KW - adult patients

KW - whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84977147369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977147369&partnerID=8YFLogxK

U2 - 10.1038/gim.2015.142

DO - 10.1038/gim.2015.142

M3 - Article

C2 - 26633545

AN - SCOPUS:84977147369

VL - 18

SP - 678

EP - 685

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 7

ER -